Clinical Trial: Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

U.S., June 9 -- ClinicalTrials.gov registry received information related to the study (NCT07631793) titled 'Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors' on May 27.

Brief Summary: Phase I study of YKYY031 for injection in patients with advanced solid tumors

Study Start Date: May 30

Study Type: INTERVENTIONAL

Condition: Malignant Neoplasms

Intervention: DRUG: YKYY031 group (the first stage)

Eligible participants selected through screening will be sequentially assigned to dose groups A1 to A6 (in ascending order of dose) according to their enrollment sequence. Each participant will receive a single intramuscular injection of the corresponding dose of YKYY031 for injection.

DRUG: YKYY031 group...